The CIRSE (Cardiovascular and Interventional Radiological Society of Europe) Congress is one of the most important international events in the Interventional Radiology Community. Every year, the congress attracts thousands of specialists from all over the world who share experience and knowledge about the latest scientific achievements and get acquainted with the most advanced solutions and innovations of Interventional Radiology and Interventional Oncology.
This year, the CIRSE Congress was held on September 14-18 in the Portuguese city of Lisbon. The congress discussed the latest clinical trials and studies that shape the future of modern medicine and Interventional Radiology. One of the key topics of congressional discussions and presentations – minimally invasive treatment techniques – ablation of tumors, embolization of blood vessels and other important methods that will be able to replace traditional surgery in the future.
During the congress, Ambercell team met with the most important partners of the company, including Terumo, Maviq, IGEA, VARIAN and CASCINATION, with whom further opportunities for cooperation and the development of innovative solutions in the Baltic States were discussed.
The exchange of knowledge and experiences, discussions, hands-on sessions, presentations of the latest medical technologies and clinical trials at the CIRSE Congress allow doctors to apply more advanced and effective treatment methods focused on patient well-being and a more efficient, safer health care system.






